http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2552332-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06abb0054a7d2b9ef7d29e54a31a7bcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e5e5e94fa9f6e50f983b19801ed38dc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7299bd8d68471b7727e5df0a099bafaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_412aaa3016a18141a37cc890cbcd3c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a978f9ce977ff8a70156b8f79392085
publicationDate 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2552332-C1
titleOfInvention Method of treating of planocellular intraepithelial lesions of cervix of uterus
abstract FIELD: medicine. n SUBSTANCE: vaginal suppositories "Cervicon-DIM", containing diindolylmethane, are applied. The medication is applied for not less than 6 months in dosage 200 mg/day of diindolylmethane. The claimed method ensures durative anti-recurrence effect for not less than a year after the completion of the therapy, as well as stimulates the immune system, including general and local immunity of the vaginal mucosa. n EFFECT: invention contributes to the acceleration of epithelisation after carrying out destructive therapy concerning cervical intraepithelial neoplasia, makes it possible to reduce or eliminate the negative impact of side effects. n 4 cl, 5 tbl, 5 ex, 2 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022060245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618427-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2740250-C1
priorityDate 2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2318510-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6399645-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7384972-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450235101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86598188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38072
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15865313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449940800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124604970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61373
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449020203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425482595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552441
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070

Total number of triples: 51.